Depomed
Quick facts
Marketed products
- Diclofenac Potassium for Oral Solution · Pain Management / Rheumatology
Diclofenac potassium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing pain and inflammation. - Gabapentin Extended Release
- Zipsor® · Pain Management / Rheumatology
Zipsor is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease inflammation and pain.
Phase 3 pipeline
- Gabapentin Extended Release tablets · Neurology / Pain Management
Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
Phase 2 pipeline
- DM-1992 · Pain
DM-1992 is a small molecule that targets the central nervous system to treat pain. - Sinemet IR
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: